You may already be familiar with its brand names, Ozempic, Wegovy, Mounjaro, and Rybelsus
Clinical Relevance: Vyleesi, the commercial name for Bremelanotide, is only available in injectable form
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
A real Copper Tripeptide-1 listing on the ingredient panel, ideally in the top half of the list
Camajani E, Feraco A, Verde L, Moriconi E, Marchetti M, Colao A, et al
The chemical constituents include lauric acid, myristic acid, sitostenone, sitosterol, and ursolic acid